eslicarbazepine acetate has been researched along with levetiracetam in 7 studies
Studies (eslicarbazepine acetate) | Trials (eslicarbazepine acetate) | Recent Studies (post-2010) (eslicarbazepine acetate) | Studies (levetiracetam) | Trials (levetiracetam) | Recent Studies (post-2010) (levetiracetam) |
---|---|---|---|---|---|
229 | 68 | 175 | 2,854 | 417 | 1,822 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Brodie, MJ; Stephen, LJ; Wishart, A | 1 |
Chen, C; Chen, G; Jiang, D; Jiang, R; Li, G; Li, J; Shao, M; Tian, H; Xue, R; Zhuo, C | 1 |
Ahmed, A; Henley, W; Jalihal, V; McLean, BN; Parrett, M; Sander, JW; Shankar, R; Tittensor, P | 1 |
Blum, D; Fiedler-Kelly, J; Galluppi, G; Hopkins, S; Ludwig, E; Sunkaraneni, S | 1 |
Bialer, M; Franco, V; Odi, R; Perucca, E | 1 |
Blum, D; Cantu, D; Gidal, B; Grinnell, T; Hixson, J; Mehta, D; Pikalov, A; Zhang, Y | 1 |
Aboumatar, S; Cantu, D; Grinnell, T; Krishnaiengar, SR; Zhang, Y | 1 |
2 review(s) available for eslicarbazepine acetate and levetiracetam
Article | Year |
---|---|
Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.
Topics: Anticonvulsants; Dibenzazepines; Drug Resistant Epilepsy; Humans; Levetiracetam; Network Meta-Analysis; Nitriles; Pyridones; Topiramate | 2017 |
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Topics: Anticonvulsants; Area Under Curve; Biological Variation, Individual; Dibenzazepines; Drug Substitution; Drugs, Generic; Europe; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregabalin; Therapeutic Equivalency; Topiramate; Vigabatrin; Zonisamide | 2021 |
2 trial(s) available for eslicarbazepine acetate and levetiracetam
Article | Year |
---|---|
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.
Topics: Anticonvulsants; Dibenzazepines; Double-Blind Method; Humans; Lamotrigine; Levetiracetam; Quality of Life; Seizures; Treatment Outcome | 2021 |
Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial.
Topics: Adult; Anticonvulsants; Dibenzazepines; Double-Blind Method; Humans; Lamotrigine; Levetiracetam; Seizures; Treatment Outcome | 2023 |
3 other study(ies) available for eslicarbazepine acetate and levetiracetam
Article | Year |
---|---|
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Fructose; Humans; Lacosamide; Levetiracetam; Male; Medical Audit; Mental Disorders; Middle Aged; Nitriles; Piracetam; Pregabalin; Prospective Studies; Pyridones; Retrospective Studies; Seizures; Sodium Channel Blockers; Topiramate; Young Adult | 2017 |
Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Seizures; Substance Withdrawal Syndrome; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2018 |
Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dibenzazepines; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Phenobarbital; Seizures | 2018 |